Healthcare Ai Acquisition's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Healthcare Ai Acquisition (HAIUF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Healthcare Ai Acquisition vs Its Competitors
- Scale: Healthcare Ai Acquisition ranks #157 of 249 companies by market capitalization in the Blank Checks industry, holding 0.1% of industry market cap.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
Healthcare Ai Acquisition's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Healthcare Ai Acquisition Corp | - | - | - | Yes |
| Competitors combined (1) | - | - | - | |
| Similar-Size Competitors (10) | - | - |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
HAIUF Stock Performance relative to its Competitors
HAIUF Stock Performance relative to Similar-Size Competitors
Healthcare Ai Acquisition's Comment on Competition and Industry Peers
Publicly Traded Peers of Healthcare Ai Acquisition Corp
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Healthcare Ai Acquisition Corp | 16.97 | - |
| Strategic Acquisitions Inc | 18.34 | 0.08 |
| SUBTOTAL | 35.31 | 0.08 |
Sources: Healthcare Ai Acquisition Corp's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Healthcare Ai Acquisition Corp versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Healthcare Ai Acquisition's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Strategic Acquisitions Inc | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Healthcare Ai Acquisition's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
Healthcare Ai Acquisition's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | 17 | - | - |
| Strategic Acquisitions Inc | 18 | 42,456 | -37,956 |
| PEERS TOTAL | 18 | 42,456 | -37,956 |
Healthcare Ai Acquisition's Position in Industry Market Structure
Market-capitalization share and concentration across all 183 companies in Healthcare Ai Acquisition's industry classification, broader than the peer set above. Market cap in millions of $.Healthcare Ai Acquisition ranks #157 of 183 companies by market capitalization in its industry, holding 0.05 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 119, indicating a unconcentrated market structure (U.S. antitrust guidance: below 1,500 unconcentrated, 1,500 to 2,500 moderately concentrated, above 2,500 highly concentrated).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Dutch Oven Gold Group Inc | 1,710 | 5.52 % |
| 2 | Jaws Mustang Acquisition Corporation | 940 | 3.04 % |
| 3 | Mntn Inc | 834 | 2.69 % |
| 4 | Constellation Acquisition Corp I | 677 | 2.19 % |
| 5 | Drugs Made In America Acquisition Ii Corp | 1,234 | 5.2% |
| 6 | Cantor Equity Partners Iv Inc | 1,234 | 5.2% |
| 7 | Sound Point Acquisition Corp I Ltd | 1,234 | 5.2% |
| 8 | Armada Acquisition Corp Ii | 1,234 | 5.2% |
| 9 | American Exceptionalism Acquisition Corp A | 1,234 | 5.2% |
| 10 | Gores Holdings X Inc | 1,234 | 5.2% |
| 157 | Healthcare Ai Acquisition Corp | 17 | 0.05 % |
Market cap and industry share for the rest of Healthcare Ai Acquisition's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-09-30.
Healthcare Ai Acquisition's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 152 | Newbury Street Acquisition Corp | 20 | - |
| 153 | Quetta Acquisition Corporation | 20 | 5.46 % |
| 154 | Starry Sea Acquisition Corp | 20 | - |
| 155 | Dt Cloud Star Acquisition Corporation | 20 | - |
| 156 | Cslm Digital Asset Acquisition Corp Iii Ltd | 1,234 | 12.3% |
| 157 | Healthcare Ai Acquisition Corp | 17 | - |
| 158 | Jatt Ii Acquisition Corp | 1,234 | 12.3% |
| 159 | Ib Acquisition Corp | 1,234 | 12.3% |
| 160 | Sentinel Energy Services Inc | 1,234 | 12.3% |
| 161 | Bhav Acquisition Corp | 1,234 | 12.3% |
| 162 | Papaya Growth Opportunity Corp I | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Healthcare Ai Acquisition's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-10-01. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Healthcare Ai Acquisition's Valuation vs Competitive Position
Valuation multiples vs the Blank Checks industry average (68 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Blank Checks industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 45.2x | - |
| EV / EBITDA | - | 26.4x | - |
| P/B | -17.5x | 6.7x | -24.2x |
| Return on Equity | - | industry aggregate | - |
| Return on Invested Capital | - | 0.96 % (avg) | - |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Healthcare Ai Acquisition's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue Growth | - | - | - | - |
| Operating Margin | - | - | - | - |
| Return on Invested Capital | - | -0.57 % | -1.94 % | - |
| P/E | - | - | 38.9x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Healthcare Ai Acquisition's BCG Growth-Share Matrix
Relative market share (vs Healthcare Ai Acquisition's largest competitor by market cap) against industry revenue growth, using the standard textbook thresholds (1.0x share, 10% growth) a common framework, not a precision instrument.
Healthcare Ai Acquisition falls in the Question Mark quadrant: relative market share of 0.01x vs its largest competitor, in an industry growing revenue 27.5% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Healthcare Ai Acquisition's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 119 (see Industry Market Structure & Concentration above) |
| Supplier Power | Not covered on this page | See Healthcare Ai Acquisition's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Healthcare Ai Acquisition's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Healthcare Ai Acquisition's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Healthcare Ai Acquisition falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Healthcare Ai Acquisition's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Low relative market share vs the industry leader (0.01x).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- Industry revenue growing at a healthy 27.5% median pace.
- A meaningful share of tracked competitors (100.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Healthcare Ai Acquisition's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | 0.00 | 1.97 | - |
| Strategic Acquisitions Inc | 5.55 | 7.82 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Healthcare Ai Acquisition's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | Q2 2025 | - | - |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
| PEERS TOTAL | - | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Healthcare Ai Acquisition's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | Q2 2025 | - | - |
| Strategic Acquisitions Inc | Q2 2026 | - | - |
Healthcare Ai Acquisition's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Healthcare Ai Acquisition Corp | - | - | - |
| Strategic Acquisitions Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Healthcare Ai Acquisition's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Healthcare Ai Acquisition Corp | - | - |
| Strategic Acquisitions Inc | - | 215.96 |
| PEERS AVERAGE | - | 415.82 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.